✦ LIBER ✦

Treatment of patients with advanced cancer of the prostate: Phase III trial, zoladex against castration; a study of the British prostate group

✍ Scribed by A.O. Turkes; W.B. Peeling; K. Griffiths

Book ID: 116006314
Publisher: Elsevier Science
Year: 1987
Tongue: English
Weight: 658 KB
Volume: 27
Category: Article
ISSN: 0022-4731
DOI: 10.1016/0022-4731(87)90352-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase III Randomised Study of Zoladex ve

Phase III Randomised Study of Zoladex versus Stilboestrol in the Treatment of Advanced Prostate Cancer

✍ B. WAYMONT; T. H. LYNCH; J. A. DUNN; L. A. EMTAGE; D. G. ARKELL; D. M. A. WALLAC 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 470 KB

Multicenter randomized trial comparing z

Multicenter randomized trial comparing zoladex with zoladex plus flutamide in the treatment of advanced prostate cancer. Survival update

✍ C. J. Tyrrell; J. E. Altwein; F. Klippel; E. Varenhorst; G. Lunglmayr; F. Boccar 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB 👁 2 views

A multicentre randomised trial comparing

A multicentre randomised trial comparing the LHRH agonist ‘Zoladex’ with ‘Zoladex’ in combination with flutamide in the treatment of advanced prostate cancer

📂 Article 📅 1990 🏛 Elsevier Science ⚖ 130 KB

Randomised phase II/III study of docetax

Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro)

✍ H.J. Meulenbeld; E.D. van Werkhoven; J.L.L.M. Coenen; G.J. Creemers; O.J.L. Loos 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 674 KB

Re: Design and Endpoints of Clinical Tri

Re: Design and Endpoints of Clinical Trials in Patients with Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group

✍ Laurence Collette 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 79 KB

A phase II study of fenretinide in patie

A phase II study of fenretinide in patients with hormone refractory prostate cancer: a trial of the Cancer Therapeutics Research Group

✍ M. M. Moore; M. Stockler; R. Lim; T. S. K. Mok; M. Millward; M. J. Boyer 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 228 KB